Medicus Pharma Ltd. Common Stock
MDCXHealthcare|Biotechnology|CA
$1.87
+0.04 (+2.19%)
DCF Value
$4.14
Cash / Share
$4.56
About
Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.
Stock Price
-98.5%(1Y)
1M
-63.3%
3M
-87.5%
6M
-88.8%
YTD
-97.6%
1Y
-98.4%
3Y
-98.6%
5Y
-98.6%
Pipeline Summary
0 total trials0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
Key Facts
Market Cap$2.7M
Employees16 (+33% YoY)
CEORaza Bokhari
IPO DateNov 15, 2024
Beta-0.61
52-Week Range$1.7 – $127.5
Avg Volume87,899
ExchangeNASDAQ
Websitemedicuspharma.com
Ownership
Float73.4%
Shares Outstanding1.4M
Recent Insider Trades
Smith Andrew AlasdairAWARD
Sep 4, 2026735,294 shares @ $0.17
Smith Andrew AlasdairAWARD
Sep 4, 2026125,000 shares @ $0.17
Mehmud FaisalAWARD
Sep 4, 20261,470,588 shares @ $0.17
Mehmud FaisalAWARD
Sep 4, 2026250,000 shares @ $0.17
Brennan Edward J.AWARD
Sep 4, 2026588,235 shares @ $0.17
Peers
Recent News
Medicus Pharma to Present at BIO-Europe 2026
Nov 5, 2026 · globenewswire.com
Medicus Pharma to Host Third Quarter 2026 Financial Performance and Business Update Call on November 9, 2026
Nov 4, 2026 · globenewswire.com
Medicus Pharma Announces Proposed SkinJect® Business Combination and Concurrent Financing
Nov 4, 2026 · globenewswire.com
Medicus Pharma to Present at BioFuture and Global Biotechnology Summit
Oct 27, 2026 · globenewswire.com
Medicus Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Oct 26, 2026 · globenewswire.com
Data last updated: Nov 9, 2026, 04:21 AM